XM无法为美国居民提供服务。
R
R

Regeneron

交易方向

交易者偏好

技术摘要

每小时

市场新闻

French and Benelux stocks-Factors to watch

French and Benelux stocks-Factors to watch Sept 16 (Reuters) - Below are company-related news and stories from France and Benelux which could have an impact on the region's markets or individual stocks. REXEL RXL.PA : QXO QXO.O , the company billionaire Brad Jacobs is seeking to launch into building services, recently made an offer of around $9.4 billion to acquire Rexel RXL.PA that the French company on Sunday said it had rebuffed .
R
R
S
F
N
U

US FDA approves Eli Lilly's drug for eczema

UPDATE 2-US FDA approves Eli Lilly's drug for eczema Adds details on disease in paragraph 3, patient population in paragraph 6, other treatments in paragraphs 7-8, details on drug in paragraphs 8-9 Sept 13 (Reuters) - Eli Lilly LLY.N said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above 12 years old.
P
R
S

Regeneron and Sanofi win another U.S regulatory approval for their Dupixent product

BRIEF-Regeneron and Sanofi win another U.S regulatory approval for their Dupixent product Sept 13 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O /SANOFI SASY.PA : DUPIXENT® (DUPILUMAB) APPROVED IN THE U.S. AS FIRST AND ONLY TREATMENT FOR ADOLESCENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) Regeneron Pharmaceuticals and Sanofi today announced that the U.S.
R
S

Sanofi: Dupixent Meets Primary Endpoints In ADEPT pivotal study in BP

BRIEF-Sanofi: Dupixent Meets Primary Endpoints In ADEPT pivotal study in BP Sept 11 (Reuters) - Sanofi SA SASY.PA : DUPIXENT IS THE FIRST AND ONLY BIOLOGIC TO ACHIEVE SIGNIFICANT IMPROVEMENTS IN DISEASE REMISSION AND SYMPTOMS IN BULLOUS PEMPHIGOID POSITIVE PIVOTAL STUDY STUDY MET PRIMARY AND ALL KEY SECONDARY ENDPOINTS IN ADULTS WITH MODERATE-TO-SEVERE DISEASE FIVE TIMES MORE PATIENTS ACHIEVED SUSTAINED DISEASE REMISSION WITH DUPIXENT THAN PLACEBO STUDY WILL SUPPORT REGULATORY SUBMISSIONS AROUND
R
S

U.S. Exlservice Holdings, Steel Dynamics, US Steel

U.S. RESEARCH ROUNDUP-Exlservice Holdings, Steel Dynamics, US Steel Sept 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Exlservice Holdings, Steel Dynamics and U.S. Steel Corp, on Monday. HIGHLIGHTS * Essex Property Trust Inc ESS.N : BMO raises target price to $310 from $294 * Exlservice Holdings Inc EXLS.O : Jefferies raises to buy from hold * Steel Dynamics Inc STLD.O : JP Morgan raises to neutral from underweig
C
R
S
U
E
U
C
C
H
U

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明